Jamm Technologies

Jamm develops and markets innovative, FDA cleared, radio frequency identification (RFID) technologies and products to identify implantable medical devices, in vivo, on demand, at the point of care.

Our technology, known as QInside ID Technology, is designed to identify implantable medical devices through distribution and use, which is critical to patient safety in the event of a device issue, update or device recall. The QInside platform complies with all FDA UDI guidelines and HIPAA Privacy Rules.  Jamm's core technology evolved from implantable RFID micro-transponder technology that has been used safely and effectively in the healthcare community for over two decades.

Jamm is also developing an informatics and data analytics platform and ecosystem that fully complies with HIPAA Privacy Rules and will enable medical device companies to gain valuable treatment regimen data that can be used in many applications to improve patient healthcare and outcomes. Such examples include using data from the QInside platform in supply chain management for medical device manufacturers and healthcare institutions, quality and reimbursement controls for hospitals, and treatment regimen data for patients receiving chemotherapy and radiation therapy.

Jamm has a broad portfolio of patents and patent applications in the U.S. and internationally. These patents protect Jamm's medical device identification and radiation dosimeter technologies and is being leveraged to protect other RFID-enabled biosensor technologies.